| |
Dermatology Other
|
|
| |
|
|
| |
|
|
|
|
|
personal edition > dermatology other > webcasts/CME
Webcasts/CME
E-Mail this webcast/CME to a colleague
Targeting Epigenetic Mechanisms for the Treatment of Cancer
| Presented by: | The University of Kentucky College of Medicine |
| Lecturer | Owen O'Connor, MD, PhD |
| Approximate duration: | Not available |
| Summary points: | This audiovisual presentation discusses the rationale and preclinical evidence underlying the development of the two major classes of epigenetics-based antineoplastics, patient populations that appear to be most likely to benefit from the use of epigentics-based agents, emrging clinical data on the potential use of these agents for solid tumours in general and lung tumours in particular, and evidence regarding the use of these agents for cutaneous T-cell lymphomas. |
| Accreditation: | The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits.
Expiration date: January 1, 2007. |
| Other: | |
Additional Information
| Audio: | Yes | |
| Video: | Yes | |
| Text: | No | |
| Pictures/Slides: | Yes | |
| Discussion group: | No | |
| Feedback possible: | No | |
| Minimum connection needed: | 28.8 | |
| Plugins needed: | No |
| Registration: | No | |
Go to webcast/CME
E-Mail this webcast/CME to a colleague
 Remind me of this
All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.
|
|
